PharmaShots | Incisive News in 3 Shots

Subscribe Now

Zydus Group

Zydus Group Reports Real-World Study Results of Exemptia (biosimilar, adalimumab) for Ankylosing Spondylitis

Zydus Group Reports Real-World Study Results of Exemptia (biosimilar, adalimumab) for Ankylosing Spondylitis

July 8, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us